Evidence map›Paper›PMID 32496514›Full record

ReviewNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2021

Estimating the Population Health Impact of Recently Introduced Modified Risk Tobacco Products: A Comparison of Different Approaches.

Peter N Lee, David Abrams, Annette Bachand, Gizelle Baker, Ryan Black, Oscar Camacho, Geoffrey Curtin, Smilja Djurdjevic, Andrew Hill, David Mendez and 8 more

Erratum issuedAbstract readComparative StudyReview
In one paragraph

Review in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. A Decision-Theoretic Public Health Framework for Heated Tobacco and Nicotine Vaping Products.International journal of environmental research and public health · 2022
    Article
  9. Article
  10. Article
  11. A Magic Bullet? The Potential Impact of E-Cigarettes on the Toll of Cigarette Smoking.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2021
    Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Peter N LeeMedical Statistics and Epidemiology, P N Lee Statistics and Computing Ltd, Sutton, Surrey, UK.
David AbramsSocial and Behavioral Sciences, NYU School of Public Health, New York, NY.
Annette BachandHealth Sciences, Ramboll US Corporation, Amherst, MA.
Gizelle BakerClinical Science and Epidemiology, Philip Morris R&D, Philip Morris Products SA, Neuchâtel, Switzerland.
Ryan BlackRegulatory Affairs, Altria Client Services LLC, Richmond, VA.
Oscar CamachoComputational Tools and Statistics, British American Tobacco (Investments) Ltd, Group R&D, Southampton, UK.
Geoffrey CurtinScientific and Regulatory Affairs, Reynolds American Inc Services Company, Winston-Salem, NC.
Smilja DjurdjevicClinical Science and Epidemiology, Philip Morris R&D, Philip Morris Products SA, Neuchâtel, Switzerland.
Andrew HillModelling, Ventana Systems UK Ltd, Salisbury, UK.
David MendezDepartment of Health Management and Policy School of Public Health, University of Michigan, Ann Arbor, MI.
Raheema S Muhammad-KahRegulatory Affairs, Altria Client Services LLC, Richmond, VA.
Jose Luis MurilloRegulatory Affairs, Altria Client Services LLC, Richmond, VA.
Raymond NiauraSocial and Behavioral Sciences, NYU School of Public Health, New York, NY.
Yezdi B PithawallaRegulatory Affairs, Altria Client Services LLC, Richmond, VA.
Bill PolandStrategic Consulting, Certara USA Inc, Menlo Park, CA.
Sandra SulskyHealth Sciences, Ramboll US Corporation, Amherst, MA.
Lai WeiRegulatory Affairs, Altria Client Services LLC, Richmond, VA.
Rolf WeitkunatClinical Science and Epidemiology, Philip Morris R&D, Philip Morris Products SA, Neuchâtel, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionVarious approaches have been used to estimate the population health impact of introducing a Modified Risk Tobacco Product (MRTP). AIMS AND

methodsWe aimed to compare and contrast aspects of models considering effects on mortality that were known to experts attending a meeting on models in 2018.

resultsThirteen models are described, some focussing on e-cigarettes, others more general. Most models are cohort-based, comparing results with or without MRTP introduction. They typically start with a population with known smoking habits and then use transition probabilities either to update smoking habits in the "null scenario" or joint smoking and MRTP habits in an "alternative scenario". The models vary in the tobacco groups and transition probabilities considered. Based on aspects of the tobacco history developed, the models compare mortality risks, and sometimes life-years lost and health costs, between scenarios. Estimating effects on population health depends on frequency of use of the MRTP and smoking, and the extent to which the products expose users to harmful constituents. Strengths and weaknesses of the approaches are summarized.

conclusionsDespite methodological differences, most modellers have assumed the increase in risk of mortality from MRTP use, relative to that from cigarette smoking, to be very low and have concluded that MRTP introduction is likely to have a beneficial impact. Further model development, supplemented by preliminary results from well-designed epidemiological studies, should enable more precise prediction of the anticipated effects of MRTP introduction. IMPLICATIONS: There is a need to estimate the population health impact of introducing modified risk nicotine-containing products for smokers unwilling or unable to quit. This paper reviews a variety of modeling methodologies proposed to do this, and discusses the implications of the different approaches. It should assist modelers in refining and improving their models, and help toward providing authorities with more reliable estimates.

Indexed as

Electronic Nicotine Delivery SystemsHumansModels, TheoreticalPopulation HealthRisk FactorsTobacco ProductsTobacco Use Disorder

Identifiers

PMID32496514
PMCPMC7885777

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.